TSHA
Taysha Gene·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TSHA Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-01 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-28
Form 144 - Report of proposed sale of securities
Ownership
2025-11-28 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-04
Taysha Gene Therapies, Inc. (TSHA) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-04 · Earnings Call
Taysha Gene Therapies, Inc. (TSHA) Q3 2025 Earnings Call Transcript
2025-11-04
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-11-04 ·
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
2025-11-04
Form 8-K - Current report
Key Events
2025-11-04 · Key Events
Form 8-K - Current report
2025-11-04
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-04 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-16
Form 8-K - Current report
Key Events
2025-10-16 · Key Events
Form 8-K - Current report
2025-10-09
Form 8-K - Current report
Key Events
2025-10-09 · Key Events
Form 8-K - Current report
